Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options

Area of Science:

• Nephrology and Cardiovascular Medicine
• Biochemistry and Oxidative Stress Research

Background:

• Cardiovascular disease (CVD) is highly prevalent in chronic kidney disease (CKD) patients, exceeding risks predicted by traditional factors.
• Renal impairment exacerbates oxidative stress due to heightened oxidant activity and diminished antioxidant defenses, worsening with disease progression.
• Inflammation in CKD further intensifies oxidant generation, creating a pro-oxidative environment.

Purpose of the Study:

• To investigate the role of oxidative stress in cardiovascular complications in chronic kidney disease (CKD).
• To explore the link between oxidative stress, endothelial dysfunction, and left ventricular hypertrophy in CKD.
• To assess potential therapeutic strategies targeting oxidative stress reduction for cardiovascular risk management in CKD.

Main Methods:

• Review and synthesis of existing literature on oxidative stress markers and mechanisms in CKD.
• Analysis of the relationship between renal function, oxidative stress levels, and cardiovascular outcomes.
• Evaluation of clinical sequelae, including endothelial dysfunction and left ventricular hypertrophy, associated with oxidative stress in CKD.

Main Results:

• Oxidative stress is significantly elevated in CKD patients, correlating with the severity of renal dysfunction.
• Endothelial dysfunction and left ventricular hypertrophy are identified as key clinical consequences of oxidative stress in CKD.
• These conditions contribute to adverse cardiovascular events in the CKD population.

Conclusions:

• Oxidative stress is a critical, underappreciated factor in the high cardiovascular morbidity and mortality observed in CKD.
• Targeting oxidative stress represents a promising therapeutic avenue to mitigate endothelial dysfunction and left ventricular hypertrophy.
• Further research into treatments that reduce oxidative stress is warranted to improve cardiovascular outcomes in CKD patients.